The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease
- 1 May 1998
- journal article
- clinical trial
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 25 (5) , 354-362
- https://doi.org/10.1111/j.1600-051x.1998.tb02455.x
Abstract
The present clinical trial was performed to study the effect of systemic administration of metronidazole and amoxicillin as an adjunct to mechanical therapy in patients with advanced periodontal disease. 16 individuals, 10 female and 6 male, aged 35–58 years, with advanced periodontal disease were recruited. A baseline examination included assessment of clinical. radiographical, microbiological and histopathological characteristics of periodontal disease. The 16 patients were randomly distributed into 2 different samples of 8 subjects each. One sample of subjects received during the first 2 weeks of active periodontal therapy, antibiotics administered via the systemic route (metronidazole and amoxicillin). During the corresponding period, the 2nd sample of subjects received a placebo drug (placebo sample). In each of the 16 patients, 2 quadrants (1 in the maxilla and 1 in the mandible) were exposed to non‐surgical subgingival scaling and root planing. The contralateral quadrants were left without subgingival instrumentation. Thus, 4 different treatment groups were formed; group 1: antibiotic therapy but no scaling, group 2: antibiotic therapy plus scaling, group 3: placebo therapy but no scaling, group 4: placebo therapy plus scaling. Re‐examinations regarding the clinical parameters were performed, samples of the subgingival microbiota harvested and 1 soft tissue biopsy from 1 scaled and 1 non‐scaled quadrant obtained 2 months and 12 months after the completion of active therapy. The teeth included in groups 1 and 3 were following the 12‐month examination exposed to non‐surgical periodontal therapy, and subsequently exited from the study. Groups 2 and 4 were also re‐examined 24 months after baseline. The findings demonstrated that in patients with advanced periodontal disease, systemic administration of metronidazole plus amoxicillin resulted in (i) an improvement of the periodontal conditions, (ii) elimination/suppression of putative periodontal pathogens such as A. actinomycetemcomitans, P. gingivalis, P. intermedia and (iii) reduction of the size of the inflammatory lesion. The antibiotic regimen alone, however, was less effective than mechanical therapy with respect to reduction of BoP—positive sites, probing pocket depth reduction, probing attachment gain. The combined mechanical and systemic antibiotic therapy (group 2) was more effective than mechanical therapy alone in terms of improvement of clinical and microbiological features of periodontal disease.Keywords
This publication has 28 references indexed in Scilit:
- Surgical Pocket TherapyAnnals of Periodontology, 1996
- Systemic antibiotic therapy in periodonticsPeriodontology 2000, 1996
- Metronidazole susceptibility factors in Actinobacillus actinomycetemcomitansJournal of Antimicrobial Chemotherapy, 1995
- A comparison of two transport media for saliva and subgingival samplesOral Microbiology and Immunology, 1993
- The effect of supragingival plaque control on the subgingival microbiota in subjects with periodontal diseaseJournal of Clinical Periodontology, 1992
- The role of histopathology in the diagnosis and prognosis of periodontal diseasesJournal of Clinical Periodontology, 1990
- Microbiology in Diagnosis and Treatment of Severe Periodontitis. A Report of Four CasesThe Journal of Periodontology, 1989
- Bacterial Invasion in Root Cementum and Radicular Dentin of Periodontally Diseased Teeth in HumansThe Journal of Periodontology, 1988
- Use of metronidazole as a probe in the study of human periodontal diseaseJournal of Clinical Periodontology, 1983